193 related articles for article (PubMed ID: 32641239)
1. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
Bernard L; Boucher J; Helpman L
Gynecol Oncol; 2020 Sep; 158(3):597-602. PubMed ID: 32641239
[TBL] [Abstract][Full Text] [Related]
2. Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery.
Manning-Geist B; Cathcart AM; Sullivan MW; Pelletier A; Cham S; Muto MG; Del Carmen M; Growdon WB; Sisodia RC; Berkowitz R; Worley M
Int J Gynecol Cancer; 2021 Oct; 31(10):1356-1362. PubMed ID: 34518239
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
4. Appendectomy at the time of ovarian cancer staging increases infectious complications: a National Surgical Quality Improvement Program (NSQIP) propensity score-stratified analysis.
Bernard L; Chen I; Le T
Int J Gynecol Cancer; 2020 Oct; 30(10):1542-1547. PubMed ID: 32848024
[TBL] [Abstract][Full Text] [Related]
5. Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.
Narasimhulu DM; Bews KA; Hanson KT; Chang YH; Dowdy SC; Cliby WA
Gynecol Oncol; 2020 Feb; 156(2):278-283. PubMed ID: 31785863
[TBL] [Abstract][Full Text] [Related]
6. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
[TBL] [Abstract][Full Text] [Related]
7. The role of bowel surgery with cytoreduction for epithelial ovarian cancer.
Cai HB; Zhou YF; Chen HZ; Hou HY
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):757-62. PubMed ID: 17889517
[TBL] [Abstract][Full Text] [Related]
8. Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
Sanders BE; Saharti S; Laus K; Bristow RE; Eskander RN
J Obstet Gynaecol; 2021 Aug; 41(6):956-961. PubMed ID: 33228421
[TBL] [Abstract][Full Text] [Related]
9. Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer?
Nica A; Covens A; Parra-Herran C; May T
Gynecol Oncol; 2020 Sep; 158(3):622-630. PubMed ID: 32561124
[TBL] [Abstract][Full Text] [Related]
10. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
[TBL] [Abstract][Full Text] [Related]
11. Mechanical and oral antibiotic bowel preparation in ovarian cancer debulking: Are we lowering or just trading surgical complications?
Wang CC; Al-Rubaye R; Tran V; Montemorano L; Al-Niaimi A
Gynecol Oncol; 2022 Jul; 166(1):76-84. PubMed ID: 35589434
[TBL] [Abstract][Full Text] [Related]
12. Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer.
Son JH; Kong TW; Paek J; Chang SJ; Ryu HS
J Surg Oncol; 2019 Jun; 119(7):1011-1015. PubMed ID: 30737795
[TBL] [Abstract][Full Text] [Related]
13. Postoperative complications in women with ovarian cancer stratified by cytoreductive surgery outcome.
Polan RM; Slota JM; Barber EL
J Surg Oncol; 2023 Oct; 128(5):891-901. PubMed ID: 37382209
[TBL] [Abstract][Full Text] [Related]
14. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
15. Abdominoperineal Resection, Pelvic Exenteration, and Additional Organ Resection Increase the Risk of Surgical Site Infection after Elective Colorectal Surgery: An American College of Surgeons National Surgical Quality Improvement Program Analysis.
Kwaan MR; Melton GB; Madoff RD; Chipman JG
Surg Infect (Larchmt); 2015 Dec; 16(6):675-83. PubMed ID: 26237302
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian Cancer.
Lippitt MH; Fairbairn MG; Matsuno R; Stone RL; Tanner EJ; Wick EC; Angarita AC; Roche KL; Levinson KL; Bergstrom JE; Sinno AK; Curless MS; Wethington S; Temkin SM; Efron J; Hobson D; Fader AN
Obstet Gynecol; 2017 Oct; 130(4):756-764. PubMed ID: 28885412
[TBL] [Abstract][Full Text] [Related]
17. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
[TBL] [Abstract][Full Text] [Related]
18. Value of pre-existent bacterial colonization in patients with advanced/relapsed ovarian neoplasms undergoing cytoreductive surgery: a multicenter observational study (BONSAI).
Fotopoulou C; Rinne N; Ghirardi V; Cunnea P; Drosou A; Tzovaras D; Giudice MT; Scambia G; Fagotti A
Int J Gynecol Cancer; 2020 Oct; 30(10):1562-1568. PubMed ID: 32817201
[TBL] [Abstract][Full Text] [Related]
19. PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.
Sánchez-Iglesias JL; Carbonell-Socias M; Pérez-Benavente MA; Monreal Clua S; Manrique-Muñoz S; García Gorriz M; Burgos-Peláez R; Segurola Gurrutxaga H; Pamies Serrano M; Pilar Gutiérrez-Barceló MD; Serrano-Castro S; Balcells-Farré MT; Pérez-Barragán C; Scaillet-Houberechts A; Cossio-Gil Y; Gil-Moreno A
Eur J Cancer; 2020 Sep; 136():149-158. PubMed ID: 32688208
[TBL] [Abstract][Full Text] [Related]
20. Postoperative pulmonary complications and outcomes in cytoreductive surgery for ovarian cancer: a propensity-matched analysis.
Xu M; Zhang W; Gao C; Zhou Y; Xie Y
BMC Anesthesiol; 2022 Apr; 22(1):120. PubMed ID: 35461230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
